- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 31.10.25 | ZimVie Inc. - 15-12G, Securities registration termination | 7 | SEC Filings | ||
| 21.10.25 | NSE/A - ZimVie Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 16 | SEC Filings | ||
| ZIMVIE Aktie jetzt für 0€ handeln | |||||
| 21.10.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.10.2025 | 1.024 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 21.10.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.10.2025.ISIN NameCA80013R2063 SANDSTORM... ► Artikel lesen | |
| 21.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 21.10.2025 | 200 | Xetra Newsboard | Das Instrument 3F80 SE0025420714 Q-LINEA AB EQUITY wird cum Kapitalmassnahme gehandelt am 21.10.2025 und ex Kapitalmassnahme am 22.10.2025 The instrument 3F80 SE0025420714 Q-LINEA AB EQUITY is traded... ► Artikel lesen | |
| 20.10.25 | NSE - ZimVie Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| 20.10.25 | ARCHIMED completes acquisition of dental implant maker ZimVie | 6 | Investing.com | ||
| 20.10.25 | ZimVie Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.10.25 | ZimVie Inc.: ZimVie Announces Completion of its Acquisition by ARCHIMED | 162 | GlobeNewswire (Europe) | PALM BEACH GARDENS, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie"), a global life sciences leader in the dental implant market, today announced that ARCHIMED, an investment firm focused... ► Artikel lesen | |
| 20.10.25 | XFRA O23: AUSSETZUNG/SUSPENSION | 106 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILZIMVIE INC. DL -... ► Artikel lesen | |
| 10.10.25 | ZimVie Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.10.25 | ZimVie Shareholders Approve Acquisition By ARCHIMED Affiliate | 8 | RTTNews | ||
| 10.10.25 | ZimVie-Aktionäre stimmen Übernahme durch ARCHIMED-Tochter zu | 12 | Investing.com Deutsch | ||
| 10.10.25 | ZimVie stockholders approve acquisition by ARCHIMED affiliate | 1 | Investing.com | ||
| 10.10.25 | ZimVie Inc.: ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED | 217 | GlobeNewswire (Europe) | PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie") (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie... ► Artikel lesen | |
| 03.10.25 | ZimVie Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.07.25 | B.Riley stuft ZimVie-Aktie nach Übernahmeankündigung auf 'Neutral' herab | 9 | Investing.com Deutsch | ||
| 31.07.25 | B.Riley downgrades ZimVie stock rating to Neutral on acquisition news | 1 | Investing.com | ||
| 30.07.25 | ZimVie Non-GAAP EPS of $0.26 beats by $0.05, revenue of $116.7M beats by $3.85M | 8 | Seeking Alpha | ||
| 30.07.25 | ZimVie Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 29.07.25 | Insights into ZimVie's Upcoming Earnings | 1 | Benzinga.com |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | +0,71 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| TELADOC HEALTH | 6,473 | -5,38 % | BofA Securities lowers Teladoc stock price target to $7.50 on segment uncertainties | ||
| ROKU | 94,03 | -2,99 % | Will Roku Dominate Streaming Stocks in 2026? | ||
| HIMS & HERS HEALTH | 30,270 | -0,20 % | Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization | ||
| BICO GROUP | 1,832 | -0,16 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,730 | -1,09 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
| DEXCOM | 60,21 | +0,65 % | Dexcom touts future at CES with new CEO Leach now leading | ||
| NUGEN MEDICAL DEVICES | 0,023 | +24,18 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| PLUS THERAPEUTICS | 0,605 | +6,42 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ in Leptomeningeal Metastases | HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| HEALWELL AI | 0,521 | -2,35 % | HEALWELL AI: HEALWELL AI Provides Additional Information Regarding November 3, 2025, Release Where it Announced Strategic Divestments | Toronto, Ontario--(Newsfile Corp. - December 31, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative... ► Artikel lesen | |
| INMODE | 13,155 | -1,16 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| HENRY SCHEIN | 67,00 | -0,33 % | Henry Schein Allows KKR To Buy Up To 19.9% Of Stake, Lifts Annual Outlook; Stock Up Over 8% | MELVILLE (dpa-AFX) - Henry Schein, Inc. (HSIC), a distributor of health care products and services, said on Tuesday that its Board has approved an amendment to the strategic partnership agreement... ► Artikel lesen |
Das Unternehmen ZIMVIE INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 16,000 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZIMVIE INC finden Sie auf Wallstreet Online.